Gefticip Tablet
Marketer
Cipla Ltd
Salt Composition
Gefitinib (250mg)
Overview Gefticip Tablet
Gefticip tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, an abnormal epidermal growth factor receptor (EGFR) gene, and no prior cancer therapy. Dosage should strictly follow your physician's instructions, continuing treatment for the duration they recommend, which depends on your individual response. Regular liver function monitoring may be advised. Common side effects are diarrhea, dry skin, anorexia, and nausea. Increased fluid intake can help mitigate these. Report any persistent or worsening side effects to your doctor, including mouth sores, vision changes, or respiratory problems. Women should use reliable contraception throughout treatment and for one month post-treatment to prevent pregnancy. Always inform your doctor of all other medications you are currently using.
Uses of Gefticip Tablet
Lung cancer (excluding small cell type)
Major Benefits of Gefticip Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gefticip Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Gefticip Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Gefticip Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gefticip Tablets can be consumed with or without food, although consistent timing is recommended.
How Gefticip Tablet works:
Gefticip tablets are an anticancer drug that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or slowing cancerous growth.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Gefticip Tablets.
PregnancyCONSULT YOUR DOCTOR
Using Gefticip Tablet during pregnancy is strongly discouraged due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Gefticip Tablet while breastfeeding is likely inadvisable. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Gefticip Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Gefticip Tablet cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Using Gefticip Tablet in patients with liver disease appears to pose minimal risk. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Gefticip Tablet :
Omit any missed Gefticip Tablet dose; resume your usual regimen. Avoid taking a double dose.
Facts to Know About Gefticip Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
3,018 People bought this recently